10-17961740-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001145195.2(SLC39A12):āc.421A>Gā(p.Lys141Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000483 in 1,613,988 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001145195.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC39A12 | NM_001145195.2 | c.421A>G | p.Lys141Glu | missense_variant | 3/13 | ENST00000377369.7 | NP_001138667.1 | |
SLC39A12 | NM_001282733.2 | c.421A>G | p.Lys141Glu | missense_variant | 3/13 | NP_001269662.1 | ||
SLC39A12 | NM_152725.4 | c.421A>G | p.Lys141Glu | missense_variant | 3/12 | NP_689938.2 | ||
SLC39A12 | NM_001282734.2 | c.19A>G | p.Lys7Glu | missense_variant | 2/12 | NP_001269663.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC39A12 | ENST00000377369.7 | c.421A>G | p.Lys141Glu | missense_variant | 3/13 | 1 | NM_001145195.2 | ENSP00000366586.2 | ||
SLC39A12 | ENST00000377371.3 | c.421A>G | p.Lys141Glu | missense_variant | 3/13 | 1 | ENSP00000366588.3 | |||
SLC39A12 | ENST00000377374.8 | c.421A>G | p.Lys141Glu | missense_variant | 3/12 | 2 | ENSP00000366591.4 | |||
SLC39A12 | ENST00000539911.5 | c.19A>G | p.Lys7Glu | missense_variant | 2/12 | 2 | ENSP00000440445.1 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000108 AC: 27AN: 251102Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135716
GnomAD4 exome AF: 0.0000438 AC: 64AN: 1461814Hom.: 0 Cov.: 31 AF XY: 0.0000454 AC XY: 33AN XY: 727216
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152174Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 14, 2024 | The c.421A>G (p.K141E) alteration is located in exon 3 (coding exon 2) of the SLC39A12 gene. This alteration results from a A to G substitution at nucleotide position 421, causing the lysine (K) at amino acid position 141 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at